adefovir has been researched along with Chronic Kidney Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kudose, S; Lunenfeld, E; Markowitz, GS | 1 |
| Cholongitas, E; Papatheodoridis, G; Pipili, C | 1 |
| Li, Z; Liu, Z; Shen, C; Wang, W; Wang, Y; Zhao, C; Zhao, Q | 1 |
1 review(s) available for adefovir and Chronic Kidney Diseases
| Article | Year |
|---|---|
Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.
Topics: Adenine; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Organophosphonates; Renal Insufficiency, Chronic; Telbivudine; Tenofovir; Thymidine | 2014 |
2 other study(ies) available for adefovir and Chronic Kidney Diseases
| Article | Year |
|---|---|
CKD in a Patient Treated with Adefovir for Chronic Hepatitis B Virus Infection.
Topics: Adenine; Antiviral Agents; Hepatitis B, Chronic; Humans; Organophosphonates; Renal Insufficiency, Chronic | 2021 |
Circulating kidney injury molecule-1 is a novel diagnostic biomarker for renal dysfunction during long-term adefovir therapy in chronic hepatitis B.
Topics: Adenine; Adult; Antiviral Agents; Biomarkers; Cohort Studies; Female; Hepatitis A Virus Cellular Receptor 1; Hepatitis B, Chronic; Humans; Male; Organophosphonates; Renal Insufficiency, Chronic; Retrospective Studies | 2016 |